Healio

FDA approves Retacrit, an Epogen/Procrit biosimilar, for treatment of anemia

Please provide your email address to receive an email when new articles are posted on . The FDA today approved epoetin alfa-epbx, the first epoetin alfa biosimilar, for the treatment of anemia caused ...
FiercePharma

Pfizer, on third try, wins FDA nod for biosimilar of blockbuster Epogen/Procrit

After a couple of misfires, Pfizer has finally won FDA approval for its biosimilar of anemia drug Epogen/Procrit, a drug whose U.S. sales generated about $1.8 billion last year for partners Amgen and ...
The American Journal of Managed Care

FDA Approves Epoetin Alfa Biosimilar for Anemia

The FDA has approved Pfizer’s epoetin alfa-epbx (Retacrit), a biosimilar to epoetin alfa (Epogen), marking the first biosimilar approval of 2018 and the first biosimilar erythropoiesis-stimulating ...
Monthly Prescribing Reference

Epogen Multidose

Epoetin alfa 10000 Units, 20000 Units; per mL; soln for IV or SC inj; contains albumin (human) and benzyl alcohol. Individualize (see full labeling for titration). CKD: initially 50–100 Units/kg 3 ...
Medscape

First Epoetin Alfa Biosimilar Approved in the US

The US Food and Drug Administration (FDA) has approved the first biosimilar erythropoiesis-stimulating agent. The reference product is epoetin alfa (Epogen/Procrit, Amgen). The new biosimilar is ...
Medscape

Aranesp, Procrit, Epogen Linked to Risks of Pure Red Cell Aplasia, Anemia

Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...
Consumer Reports

Are anemia drugs safe?

The anemia drugs epoetin alfa (Procrit and Epogen) and darbepoetin alfa (Aranesp) are among the top-sellers in the U.S., as consumers and their insurance companies spent $7.2 billion in 2008 on this ...
GEN

Amgen Initiates Voluntary Nationwide Recall of Certain Lots of Epogen and Procrit

Products were found to contain thin glass flakes, but their potential to impact patients is expected to be low. Amgen has voluntarily recalled certain lots of Epogen® and Procrit® (epoetin alfa) vials ...
ascopubs.org

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study ...

Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. Two thousand three hundred seventy patients with nonmyeloid malignancies who ...
Nature

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a ...

Iron status is commonly assessed using serum ferritin and transferrin saturation (TSAT) values. As inflammation has an influence on these variables, other more specialized markers have come into use, ...
FiercePharma

Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)

THOUSAND OAKS, Calif., Sept. 24 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty ...